James E. Bradner insider trades
Open-market stock purchases and sales by James E. Bradner, EVP, Research and Development at Amgen Inc, from SEC Form 4 filings since Feb 9, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 7, 2026 | AMGN Amgen Inc | Sold (not open market) | $148K |
| May 6, 2026 | AMGN Amgen Inc | Sold (not open market) | $134K |
| May 5, 2026 | AMGN Amgen Inc | Bought (not open market) | — |
| May 5, 2026 | AMGN Amgen Inc | Bought (not open market) | $7.2M |
| Feb 9, 2026 | AMGN Amgen Inc | Sold (not open market) | $827K |
| Feb 9, 2026 | AMGN Amgen Inc | Sold (not open market) | $366K |
Companies traded
- AMGN Amgen Inc: other filings, last May 7, 2026